SOURCE: Cavit Sciences, Inc.

November 15, 2007 08:00 ET

Cavit Sciences, Inc. Announces Financing Update

DELRAY BEACH, FL--(Marketwire - November 15, 2007) - Cavit Sciences, Inc. ("Cavit") (OTCBB: CVIT) today announced the status of the Company's capital raising efforts.

Cavit's team has been aggressively seeking financing with terms that are beneficial to the Company and its shareholders. A financing deal will be finalized this month that will ensure the execution of Cavit's business plan and future operations. The proceeds will allow the Company to complete its facilities, hire necessary personnel, initiate the successful commercialization of its products in certain markets and provide working capital. Terms of the deal will be announced upon finalization. We anticipate the transactions to be consummated prior to November 30, 2007.

Cavit Sciences, Inc. ("Cavit") is a biotechnology company engaged in developing treatments and prevention for cancer, viral infections and related diseases. Additional information regarding our drug development, supplement line and Company information is available on the Company's website at: www.cavitsciences.com

Statements contained herein that are not historical fact may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those projected or suggested in any forward-looking statements made by Cavit. These factors include, but are not limited to: (i) the ability of Cavit to successfully raise financing, (ii) the ability of Cavit to finalize its manufacturing and distribution facilities, and (iii) the ability of Cavit to successfully commercialize its products in certain markets. Additional factors that would cause actual results to differ materially from those projected or suggested in any forward-looking statements are contained in Cavit's filings with the Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" for Cavit on Form 10K-SB filed on April 12, 2007 and its subsequently filed Forms 10-QSB.

Contact Information